SVP Mary Elizabeth Henderson sells 5,343 JAZZ shares at $194.49; retains 28,728 shares post-transaction
Henderson, SVP of Technical Operations, sold 5,343 shares at $194.49 on 2026-02-26, reducing her holding from 34,071 to 28,728 shares. The sale occurred near the 52-week high of $196.83 and represented a 15.7% reduction of her pre-transaction position. The broader context shows Jazz Pharmaceuticals reported full-year net income that was negative, though the latest quarter generated $251.4M in net income on $1.1B revenue. The stock has appreciated 15.8% over the past 30 days and 14.2% over 90 days, reaching close to its annual high. The sale size and retention of substantial holdings signal neither a major portfolio shift nor complete exit conviction.